A Review of the Treatment of Psoriasis with Infliximab

E-ISSN： 1876-1038|1|3|201-205

ISSN： 1574-8871

Source： Reviews on Recent Clinical Trials, Vol.1, Iss.3, 2006-09, pp. : 201-205

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Childhood Generalized Pustular Psoriasis: Longtime Remission With Combined Infliximab and Methotrexate Treatment

PEDIATRIC DERMATOLOGY, Vol. 32, Iss. 1, 2015-01 ,pp. : e13-e14

John Wiley & Sons Inc

Access to resources Recommend Favorite

Successful treatment with infliximab of sibling cases with generalized pustular psoriasis caused by deficiency of interleukin‐36 receptor antagonist

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY & VENEREOLOGY, Vol. 926-9959, Iss. 10, 2015-10 ,pp. : 2054-2056

John Wiley & Sons Inc

Access to resources Recommend Favorite

Successful treatment with infliximab of sibling cases with generalized pustular psoriasis caused by deficiency of interleukin‐36 receptor antagonist

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY & VENEREOLOGY, Vol. 29, Iss. 10, 2015-10 ,pp. : 2054-2056

John Wiley & Sons Inc

Access to resources Recommend Favorite

Infliximab biosimilar CT‐P13 in the treatment of chronic plaque psoriasis: data from the Psobiosimilars registry

BRITISH JOURNAL OF DERMATOLOGY, Vol. 177, Iss. 6, 2017-12 ,pp. : e325-e326

John Wiley & Sons Inc

Access to resources Recommend Favorite

Clinical experience with infliximab biosimilar in psoriasis

BRITISH JOURNAL OF DERMATOLOGY, Vol. 177, Iss. 6, 2017-12 ,pp. : e347-e348

John Wiley & Sons Inc

Access to resources Recommend Favorite